Critical

Rhesus haemolytic disease of the newborn

Neonatal · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Alloimmune haemolysis from maternal anti-D (or other) antibodies crossing the placenta, causing neonatal anaemia, hyperbilirubinaemia and hydrops.

Red flags

  • Hydrops fetalis
  • Rapidly rising bilirubin
  • Signs of kernicterus (lethargy, abnormal tone)
  • Severe anaemia

Assessment

Differential diagnosis

  • ABO haemolytic disease
  • G6PD deficiency
  • Hereditary spherocytosis
  • Sepsis
  • Other alloimmune anaemia

Investigations

  • Neonatal FBC, reticulocytes, blood film
  • Bilirubin (serial) and blood group / direct antiglobulin test
  • Maternal antibody status
  • LDH and haptoglobin
  • Assess for hydrops

Management

  • Assess for anaemia, jaundice and hydrops at birth
  • Start intensive phototherapy for hyperbilirubinaemia
  • Monitor bilirubin against exchange thresholds
  • Transfuse for severe anaemia
  • Exchange transfusion for very high or rising bilirubin
  • Neonatal / haematology involvement

Drugs & doses

Intensive phototherapy
IVIG (specialist, to reduce haemolysis)
Packed red cells / exchange transfusion

Disposition

Neonatal unit; haematology input.

Complications & pitfalls

  • Kernicterus
  • Severe anaemia / heart failure
  • Late anaemia of infancy

Exam pearls

  • Antenatal anti-D prophylaxis has made severe disease uncommon.
  • Follow national bilirubin threshold charts for phototherapy and exchange.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.